Chenthamarakshan Vasu to Female
This is a "connection" page, showing publications Chenthamarakshan Vasu has written about Female.
Connection Strength
0.436
-
Preclinical stage abundance and nuclear antigen reactivity of faecal Immunoglobulin A vary among males and females of lupus-prone mouse models. Immunology. 2022 04; 165(4):497-507.
Score: 0.043
-
Abundance and nuclear antigen reactivity of intestinal and fecal Immunoglobulin A in lupus-prone mice at younger ages correlate with the onset of eventual systemic autoimmunity. Sci Rep. 2020 08 31; 10(1):14258.
Score: 0.039
-
Dynamics of Structural and Functional Changes in Gut Microbiota during Treatment with a Microalgal ?-Glucan, Paramylon and the Impact on Gut Inflammation. Nutrients. 2020 Jul 23; 12(8).
Score: 0.039
-
Pretreatment with Yeast-Derived Complex Dietary Polysaccharides Suppresses Gut Inflammation, Alters the Microbiota Composition, and Increases Immune Regulatory Short-Chain Fatty Acid Production in C57BL/6 Mice. J Nutr. 2020 05 01; 150(5):1291-1302.
Score: 0.038
-
Gut microbiota differently contributes to intestinal immune phenotype and systemic autoimmune progression in female and male lupus-prone mice. J Autoimmun. 2020 03; 108:102420.
Score: 0.037
-
Impact of dietary deviation on disease progression and gut microbiome composition in lupus-prone SNF1 mice. Clin Exp Immunol. 2015 Aug; 181(2):323-37.
Score: 0.027
-
Response to Comment on Sofi et al. pH of Drinking Water Influences the Composition of Gut Microbiome and Type 1 Diabetes Incidence. Diabetes 2014;63:632-644. Diabetes. 2015 Aug; 64(8):e20-1.
Score: 0.027
-
Gender bias in lupus: does immune response initiated in the gut mucosa have a role? Clin Exp Immunol. 2015 Jun; 180(3):393-407.
Score: 0.027
-
pH of drinking water influences the composition of gut microbiome and type 1 diabetes incidence. Diabetes. 2014 Feb; 63(2):632-44.
Score: 0.024
-
Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes. J Immunol. 2008 Dec 15; 181(12):8323-34.
Score: 0.017
-
Preferential costimulation by CD80 results in IL-10-dependent TGF-beta1(+) -adaptive regulatory T cell generation. J Immunol. 2008 May 15; 180(10):6566-76.
Score: 0.017
-
Enhanced engagement of CTLA-4 induces antigen-specific CD4+CD25+Foxp3+ and CD4+CD25- TGF-beta 1+ adaptive regulatory T cells. J Immunol. 2007 Oct 15; 179(8):5191-203.
Score: 0.016
-
Bone marrow is a preferential homing site for autoreactive T-cells in type 1 diabetes. Diabetes. 2007 Sep; 56(9):2251-9.
Score: 0.016
-
Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificity. J Immunol. 2004 Aug 15; 173(4):2866-76.
Score: 0.013
-
Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis. J Immunol. 2003 Jun 01; 170(11):5511-22.
Score: 0.012
-
Targeted engagement of CTLA-4 prevents autoimmune thyroiditis. Int Immunol. 2003 May; 15(5):641-54.
Score: 0.012
-
CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties. Int Immunol. 2003 Feb; 15(2):167-75.
Score: 0.011
-
A novel pancreatic ?-cell targeting bispecific-antibody (BsAb) can prevent the development of type 1 diabetes in NOD mice. Clin Immunol. 2014 Jul; 153(1):187-98.
Score: 0.006
-
IL-1? promotes TGF-?1 and IL-2 dependent Foxp3 expression in regulatory T cells. PLoS One. 2011; 6(7):e21949.
Score: 0.005
-
Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function. Clin Immunol. 2009 May; 131(2):260-70.
Score: 0.004
-
IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J Immunol. 2005 Jun 01; 174(11):7006-13.
Score: 0.003
-
Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease. J Immunol. 2003 Feb 15; 170(4):2195-204.
Score: 0.003